NCT06299943 (TargetGait) is a NA clinical trial of Biofeedback gait training by biomechanical target parameter in Stroke, sponsored by Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health.

What drugs are being tested in NCT06299943?

Interventions in NCT06299943: Biofeedback gait training by biomechanical target parameter.

What condition does NCT06299943 study?

NCT06299943 studies Stroke, Biofeedback, Gait, Hemiplegic, Gait Training, Hemiparesis.

Is NCT06299943 still recruiting?

NCT06299943 is currently status unknown. Last updated 12 March 2024.

Last reviewed 2024-03-12 · How we verify

NCT06299943: TargetGait

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biofeedback Gait Training by Target Biomechanical Parameters in the Early Recovery Period of Stroke

Status unknown NA Last updated 12 March 2024

What this trial tests

NA trial testing Biofeedback gait training by biomechanical target parameter in Stroke in 120 participants. Status unknown.

Timeline

24 January 2022

Primary endpoint
30 December 2025

30 December 2025

Quick facts

Lead sponsor	Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	120
Start date	24 January 2022
Primary completion	30 December 2025
Estimated completion	30 December 2025
Sites	1 location across Russia

Drugs / interventions tested

Biofeedback gait training by biomechanical target parameter

Conditions studied

Stroke — all drugs for Stroke →
Biofeedback — all drugs for Biofeedback →
Gait, Hemiplegic — all drugs for Gait, Hemiplegic →
Gait Training — all drugs for Gait Training →

Sponsor

Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

Who can join

Adults 18 to 75, any sex, with Stroke or Biofeedback. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single-blinded controlled clinical trial. Biofeedback training courses based on target biomechanical gait parameters are being studied. For targeted biofeedback training, various biomechanical parameters are used: parameters of the gait cycle, EMG or kinematics of joint movements. The number of sessions is 8-11 for each patient. Clinical gain analysis is carried out before and after a course of training. Changes in biomechanical parameters that occurred at the end of the training course are assessed in comparison with those before training, and both statuses (before and after training) are compared with similar gait parameters in a group of healthy adults.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Typical Changes in Gait Biomechanics in Patients with Subacute Ischemic Stroke.
Skvortsov DV, Kaurkin SN, Grebenkina NV, Ivanova GE. · · 2025 · cited 5× · PMID 40075759 · DOI 10.3390/diagnostics15050511
Targeted Biofeedback Training to Improve Gait Parameters in Subacute Stroke Patients: A Single-Blind Randomized Controlled Trial.
Skvortsov DV, Kaurkin SN, Ivanova GE. · · 2024 · PMID 39598989 · DOI 10.3390/s24227212

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health trials

Trials by the same sponsor.

NCT06802159 — Rehabilitation Methods for Unilateral Spatial Neglect in Stroke Patients · NA · recruiting
NCT05309148 — Oculomotor and Cognitive Rehabilitation Using Visual Feedback in Stroke Patients · NA · unknown
NCT06143475 — Functional Proprioceptive Stimulation of the Upper Limbs in Stroke Patients · NA · completed
NCT04674293 — Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke · unknown
NCT04681235 — Virtual Reality Training Affects on Motor Functions and Mental Health in Stroke Patients · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06299943 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Last refreshed: 12 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06299943.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing